Global Medical Isotope Production Market CAGR To Be 8.29% by 2040, Due To the Growing Demand for Medical Isotopes in Diagnostic and Therapeutic Procedures| Roots Analysis

According to our latest market report "Global Medical Isotope Production Market, Till 2040 by "Scale of Operation, Type of Isotope, Radioisotope, Production Method, Application Area, Type of Diagnostic Radioisotope, Type of Therapeutic Radioisotope, Therapeutic Area, End Users, Geographical Regions and Leading Players", the global medical isotope production market size is projected to reach USD 15.06 billion by 2040 from USD 4.56 billion in 2025, growing at a CAGR of 8.29% in the forecast period.

To request quote of this report, please visit: https://www.rootsanalysis.com/reports/medical-isotope-production-market/request-quote.html

In the era of modern medicine, medical isotopes have emerged as a promising and advanced nuclear medicine solution that can be used for the diagnosis and treatment of various chronic conditions. Notably, nuclear medicine involves the use of radioisotopes in combination with biological molecules that target specific cells, tissues or organs within the human body. Currently, nuclear reactors and particle accelerators / cyclotrons are being actively used to produce a wide array of medical isotopes for both diagnostic and therapeutic applications. However, as the demand for isotopes grows, so does the need for more advanced and efficient production technologies. As a result, several partnerships and collaborations have been established by stakeholders in medical isotope domain; enabling companies to expand their respective product portfolios and enhance their capabilities and visibility in this domain.

Global Medical Isotope Production Market Segments

Based on the scale of operation, the market is segmented into commercial scale and preclinical / clinical Scale.

1. The commercial scale segment led the global medical isotope production market, capturing the largest revenue share of around 90% in the current year.
2. The preclinical / clinical scale segment is anticipated to grow at a higher CAGR of 9.21%, during the forecast period.

Based on the type of isotope, the market is segmented into radioisotopes and stable isotopes.

1. The radioisotopes segment led the global medical isotope production market, capturing the largest revenue share of over 85% in the current year.
2. In fact, the radioisotopes segment is anticipated to show the highest growth rate of 8.42%, during the forecast period.

Based on the radioisotopes, the market is segmented into Technetium-99m, Fluorine-18, Leutetium-177, Actinium-225 and other radioisotopes.

1. The Technetium-99m radioisotope segment led the global medical isotope production market, capturing the largest revenue share of around 80% in the current year.
2. The Leutetium-177 radioisotope segment is anticipated to show the highest growth rate of 10.69% during the forecast period.

Based on the production method, the market is segmented into nuclear reactors, accelerators and other methods.

1. The nuclear reactors segment led the global medical isotope production market, capturing the largest revenue share of approximately 75% in the current year.
2. The accelerators segment is anticipated to be the fastest growing segment in this industry, with an annualized rate of 11.70% during the forecast period.

To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/medical-isotope-production-market/request-sample.html

Based on the application area, the market is segmented into diagnosis, nuclear therapy and other applications.

1. The diagnosis segment led the global medical isotope production market, capturing the largest revenue share of more than 85% in the current year.
2. The nuclear therapy segment is anticipated to be the fastest growing segment in this industry, with an annualized rate of 11.00% during the forecast period.

Based on the type of diagnostic radioisotope, the market is segmented into SPECT radioisotopes and PET radioisotopes.

1. The SPECT radioisotopes segment led the global medical isotope production market, capturing the largest revenue share of around 80% in the current year.
2. The PET radioisotopes segment is anticipated to be the fastest growing segment in this industry, with an annualized rate of 8.86% during the forecast period.

Based on the type of therapeutic radioisotope, the market is segmented into beta emitters, alpha emitters and other emitters.

1. The beta emitters segment led the global medical isotope production market, capturing the largest revenue share of around 65% in the current year.
2. The alpha emitters segment is anticipated to be the fastest growing segment in this industry, with an annualized rate of 13.12% during the forecast period.

Based on the therapeutic area, the market is segmented into oncological disorders, cardiovascular disorders, neurological disorders and other disorders.

1. The oncological disorders segment led the global medical isotope production market, capturing the largest revenue share of almost 40% in the current year.
2. The neurological disorders segment is anticipated to be the fastest growing segment in this industry, with an annualized rate of 11.54% during the forecast period.

Based on end users, the market is segmented into hospitals, diagnostic centers and research institutes.

1. The hospitals segment led the global medical isotope production market, capturing the largest revenue share of around 50% in the current year.
2. The research institutes' segment is anticipated to be the fastest growing segment in this industry, with an annualized rate of 9.15% during the forecast period.

Based on the regional insights, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America.

1. North America dominated the global medical isotope production market and accounted for the largest revenue share of more than 40% in the current year.
2. In Asia-Pacific, the global medical isotope production market is anticipated to demonstrate lucrative growth during the forecast period.

Global Medical Isotope Production Market Regional Outlook
Based on the geographical regions, the global medical isotope production market can be segmented into five major regions, including North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America. Led by the US, North America is anticipated to capture the majority share of the global medical isotope production market in 2025, and this trend is likely to remain unchanged during the forecast period. Further, the medical isotope domain in Asia-Pacific is accounted to be the fastest-growing segment of the market. The growth of the medical isotope production market in the region is driven by the growing geriatric population and rise in the number of cancer and cardiovascular disease cases.

Browse Full Report Description + Research Methodology + Table of Content + Infographics here:
https://www.rootsanalysis.com/reports/medical-isotope-production-market.html

Key Report Takeaways
1. Close to 110 players are engaged in the manufacturing of isotopes / radioisotopes; of these, around 60% of the manufacturers were established post-2000
2. Close to 95 isotope manufacturers offer their isotopes / radioisotopes to both hospitals and diagnostic centers for their use across a wide range of applications, including diagnosis, nuclear therapy, research and sterilization
3. Stakeholders are actively upgrading their existing capabilities in order to enhance their respective portfolios and gain a competitive edge over other players active in the medical isotope industry
4. In the medical isotope domain, over 67% of total partnership activity has taken place within the last three years, 36% deals were focused on the supply of various isotopes (primarily Leitetium-177)
5. Since 2020, the funding and investment in this domain has surged at a CAGR of 20.5%; notably, grants / awards emerged as the most prominent funding model adopted by isotope manufacturers to raise funds
6. Using our proprietary approach, we were able to identify a comprehensive list of parameters that one should take into consideration while outsourcing medical isotope manufacturing
7. The growing incidence of cancer and inclination of healthcare providers towards early cancer diagnosis are likely to drive the isotope / radioisotope production market, positioning it for steady growth in the foreseeable future
8. Market opportunity associated with medical isotopes is likely to witness an annualized growth rate of 8.29% till 2040, owing to expanding applications of isotopes, such as Lutetium -177 and Iodine-131 in personalized therapy
9. Technetium-99m is expected to dominate the market during the forecast period till 2040, owing to its critical role in most of the diagnostic medical procedures, driving significant demand for this radioisotope
10. The medical isotope production market opportunity is expected to be well distributed across different radioisotopes, production methods and application areas
11. Driven by the increasing investment in domestic production facilities to address supply chain vulnerabilities, the US medical isotopes production market is expected to grow at CAGR of 6.84%, during the forecast period

Global Medical Isotope Production Market Key Players
Examples of top players in medical isotope production industry (have been profiled in this market report; in alphabetical order) include Actinium Pharmaceutical, Fussion Pharma, Jubilant Radiopharma, Lantheus, Kinectrics, Bayer, IRE, Novartis, Siemens Healthineers, NTP Radioisotopes, TAIYO NIPPON SANSO and Telix. This market report includes an easily searchable excel database of all the medical isotope production companies present worldwide.

Gaurav Chaudhary
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com
Website: https://www.rootsanalysis.com

Roots Analysis is a global leader in the market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

This release was published on openPR.